Smarter. Stronger. Together. Expert Guidance, Tools, and Resources to Optimize the Care of Patients With HER2-Negative Early-Stage Breast Cancer

Get up to date on the multidisciplinary care of patients with HER2-negative early-stage breast cancer with this comprehensive educational program featuring Medical Minute modules, downloadable slides, topical commentaries, a patient resource, and an interactive decision support tool providing case-specific treatment recommendations from an expert panel.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Breastcancer.org

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner